You are here

Eli Lilly

Leukemia rivals try to stay ahead as Merck, Lilly chase

Leukemia rivals try to stay ahead as Merck, Lilly chase

Biopharma Dive

Flag link:

ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data

ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data

Fierce Biotech

Flag link:

Lilly puts its cancer future in Loxo's hands

Lilly puts its cancer future in Loxo's hands

Biopharma Dive

Flag link:

Lilly putting $400M into U.S. diabetes production, adding 100 jobs

Lilly putting $400M into U.S. diabetes production, adding 100 jobs

Fierce Pharma

drug manufacturing

Flag link:

AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds

AHA: Lilly, Boehringer's Jardiance cuts CV hospitalizations over rival diabetes meds

Fierce Pharma

Boehringer Ingelheim

clinical trials

Flag link:

FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes

FDA Panel Votes Against Lilly's Jardiance for Type I Diabetes

Zacks.com

Boehringer Ingelheim

type 1 diabetes

Flag link:

Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy

Eli Lilly-backed biotech grabs $100M to dispatch antibody-oligonucleotide conjugates after muscular dystrophy

Endpoints

myotonic muscular dystrophy

Flag link:

Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure

Boehringer, Eli Lilly begin sixth phase III study for Jardiance in heart failure

Pharmaceutical Business Review

Boehringer Ingelheim

Flag link:

Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data

Eli Lilly's Taltz extends its head-to-head Humira beat with 52-week psoriatic arthritis data

Fierce Pharma

psoriatic arthritis

Flag link:

Lilly and Boehringer rejig diabetes alliance as Jardiance soars

Lilly and Boehringer rejig diabetes alliance as Jardiance soars

Pharmaforum

Boehringer Ingelheim

type 2 diabetes

Flag link:

Dogs help Eli Lilly scientists identify new osteoarthritis target

Dogs help Eli Lilly scientists identify new osteoarthritis target

Fierce Biotech

osteoarthritis in dogs

Flag link:

Lilly counts on growing markets to boost lagging Taltz, Trulicity

Lilly counts on growing markets to boost lagging Taltz, Trulicity

Fierce Pharma

type 2 diabetes

Flag link:

Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data

Eli Lilly CEO Says Drugmaker Won’t Rehash Old Alzheimer’s Data

Bloomberg

Alzheimer's disease

Flag link:

Lilly USA diabetes chief Enrique Conterno bows out after 27 years

Lilly USA diabetes chief Enrique Conterno bows out after 27 years

Fierce Pharma

Enrique Conterno

Flag link:

Eli Lilly (LLY) Surpasses Q3 Earnings Estimates

Eli Lilly (LLY) Surpasses Q3 Earnings Estimates

Yahoo/Zacks.com

Flag link:

The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict

The Week Ahead In Biotech: Earnings Trickle In, While Glaxo, Melinta, Foamix And Eton Await FDA Verdict

Yahoo/Benzinga

Gilead Sciences

Edwards Lifesciences

Baxter International

Integra LifeSciences

Phathom Pharmaceuticals

Eton Pharmaceuticals

Melinta Therapeutics

Ligand Pharmaceuticals

Flag link:

Lilly cancer drug pipeline hit by trial setback

Lilly cancer drug pipeline hit by trial setback

Biopharma Dive

pancreatic cancer

ARMO BioSciences

Flag link:

Eli Lilly to shutter neuroscience R&D center next year

Eli Lilly to shutter neuroscience R&D center next year

Fierce Biotech

Flag link:

FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades

Xconomy

Flag link:

Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful

Lilly touts Cyramza lung cancer data, as AZ’s Tagrisso grows even more powerful

Fierce Pharma

EGFR lung cancer

Flag link:

Pages